Disruption of iron metabolism resulting from Dmt1/Slc11a2 deficiency compromises Notch protein degradation and transcriptional activation
The FEBS Journal · 2026
DOI: 10.1111/febs.70522 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Rui Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology (MAASTRO/GROW) Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, The Netherlan…. Hauptthemen laut MEDLINE: Iron, Cation Transport Proteins, Transcriptional Activation, Receptors, Notch. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, China Scholarship Council.
Abstract (Originalsprache)
Notch receptor activation requires γ‐secretase‐mediated release of Notch intracellular domain 1 (NICD1) to regulate gene transcription. Here, we identify the proton‐driven solute carrier 11a2 (Slc11a2) or divalent metal transport protein Dmt1 as an inhibitor of Notch signaling via regulating iron homeostasis and lysosomal integrity. Dmt1 loss reduces ferritin levels and increases labile Fe 2+ , causing elevated reactive oxygen species (ROS) and lipid peroxidation. These changes compromise lysosomal function and impair degradation of S3‐Val1744 cleaved NICD1, resulting in its accumulation. Dmt1 has isoforms with or without an iron‐responsive element (IRE): Re‐expressing Dmt1 + IRE robustly increases ferritin heavy‐chain (FTH), whereas Dmt1‐IRE moderately elevates FTH and ferritin light‐chain (FTL), with co‐expression further enhancing FTL levels. Restoration of Dmt1 expression rescues ferritin levels, lysosomal activity, and NICD1 degradation while reducing oxidative stress and lipid peroxidation. Notably, Dmt1 deficiency decreases NICD1 binding to RBP‐Jκ/CSL and its recruitment to Notch target gene promoters Hes1 and Hey1 . Collectively, our findings demonstrate that Dmt1 regulates lysosomal function through iron homeostasis and that lysosomal dysfunction from Dmt1 loss impairs NICD1 degradation and disrupts Notch signaling, linking cellular iron metabolism and Notch pathway activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology (MAASTRO/GROW) Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, The Netherlands.
ORCID-Profile: Rui Zhang, Marc A Vooijs
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- China Scholarship Council
Zitieren
APA
Zhang, R., Ahmadian, S., Piepers, J., Bock, F., Keulers, T., & Vooijs, M. A. (2026). Disruption of iron metabolism resulting from Dmt1/Slc11a2 deficiency compromises Notch protein degradation and transcriptional activation. The FEBS Journal. https://doi.org/10.1111/febs.70522
Vancouver
Zhang R, Ahmadian S, Piepers J, Bock F, Keulers T, Vooijs MA. Disruption of iron metabolism resulting from Dmt1/Slc11a2 deficiency compromises Notch protein degradation and transcriptional activation. The FEBS Journal. 2026. doi:10.1111/febs.70522
BibTeX
@article{Zhang2026,
author = {Zhang, Rui and Ahmadian, Somaieh and Piepers, Jolanda and Bock, Florian and Keulers, Tom and Vooijs, Marc A},
title = {Disruption of iron metabolism resulting from Dmt1/Slc11a2 deficiency compromises Notch protein degradation and transcriptional activation},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70522}
}
EUVIMED